Notice for Arsenic trioxide (Phebra Pty Ltd)
Active ingredients
Arsenic trioxide
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
capsules
Indication
Treatment of acute promyelocytic leukaemia
Therapeutic area
Haematology